Published in Breast J on October 05, 2011
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am J Pathol (2004) 6.95
HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell (2008) 4.84
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature (2011) 4.07
Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol (2003) 2.67
EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod Pathol (2005) 2.37
Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems. Hum Pathol (2004) 1.80
ACR Appropriateness Criteria® acute onset flank pain--suspicion of stone disease. Ultrasound Q (2012) 1.76
ACR Appropriateness Criteria ® acute onset of scrotal pain--without trauma, without antecedent mass. Ultrasound Q (2012) 1.57
Asymmetric spermatic cord vessel enhancement and enlargement on contrast-enhanced MDCT as indicators of ipsilateral scrotal pathology. Eur J Radiol (2010) 1.44
Treatment of growing teratoma syndrome. N Engl J Med (2009) 1.43
NF-kappaB regulates androgen receptor expression and prostate cancer growth. Am J Pathol (2009) 1.35
Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens. Diagn Cytopathol (2009) 1.29
Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: an early predictor of relapse or incomplete androgen suppression. Urology (2006) 1.18
Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography. Clin Microbiol Rev (2008) 1.16
Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature. Cancer (2002) 1.14
Integrative genomic analyses of sporadic clear cell renal cell carcinoma define disease subtypes and potential new therapeutic targets. Cancer Res (2011) 1.12
The nonvisualized appendix: incidence of acute appendicitis when secondary inflammatory changes are absent. AJR Am J Roentgenol (2004) 1.08
The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression. DNA Cell Biol (2011) 1.07
miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma. Proc Natl Acad Sci U S A (2013) 1.06
Diagnosis of pneumonia with an electronic nose: correlation of vapor signature with chest computed tomography scan findings. Laryngoscope (2004) 1.04
Placental inflammation and viral infection are implicated in second trimester pregnancy loss. Am J Obstet Gynecol (2006) 0.96
Chromogenic in situ hybridization for the detection of HER-2/neu gene amplification in breast cancer with an emphasis on tumors with borderline and low-level amplification: does it measure up to fluorescence in situ hybridization? Am J Clin Pathol (2005) 0.95
Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker. Proc Natl Acad Sci U S A (2009) 0.91
Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease. Hell J Nucl Med (2012) 0.90
HER-2/neu and topoisomerase IIa gene amplification and protein expression in invasive breast carcinomas: chromogenic in situ hybridization and immunohistochemical analyses. Am J Clin Pathol (2005) 0.88
Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma. Diagn Mol Pathol (2004) 0.87
Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas enhances HIF2α activity. Cancer Discov (2013) 0.87
Acute promyelocytic leukemic involvement of the optic nerves following mitoxantrone treatment for multiple sclerosis. J Neurol Sci (2008) 0.86
Thyroid nodule fine-needle aspiration. Semin Ultrasound CT MR (2012) 0.85
Delayed cerebrospinal fluid leak following septoplasty. Ann Otol Rhinol Laryngol (2009) 0.84
Incidence of visualization of the normal appendix on different MRI sequences. Emerg Radiol (2006) 0.84
The role of modern molecular imaging techniques in gastroenterology. Gastroenterology (2008) 0.82
Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma. Cancer Biol Ther (2011) 0.82
Central photopenic lesions on FDG-PET scan in a patient with peripheral T cell lymphoma. Ann Nucl Med (2008) 0.82
Antibody-mediated rejection in heart transplant patients: long-term follow up of patients with high levels of donor-directed anti-DQ antibodies. Clin Transpl (2011) 0.82
ACR Appropriateness Criteria® posttreatment follow-up of prostate cancer. J Am Coll Radiol (2011) 0.82
MiRNA-9 and MiRNA-200a distinguish hemangioblastomas from metastatic clear cell renal cell carcinomas in the CNS. Brain Pathol (2011) 0.81
Cytomegalovirus infection of trophoblast cells elicits an inflammatory response: a possible mechanism of placental dysfunction. Am J Obstet Gynecol (2006) 0.81
Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study. J Heart Lung Transplant (2013) 0.80
Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy. Urol Oncol (2011) 0.79
Suboptimal and inadequate quantification: an alarming crisis in medical applications of PET. Eur J Nucl Med Mol Imaging (2011) 0.78
Correlates of valvular ossification in patients with aortic valve stenosis. Clin Transl Sci (2009) 0.78
Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET. Eur J Nucl Med Mol Imaging (2008) 0.78
Perspectives on radiation dose in abdominal imaging. Abdom Imaging (2013) 0.78
Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study. Ann Diagn Pathol (2012) 0.77
Phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors. Cancer (2014) 0.76
Expression of glial cell line-derived neurotropic factor receptor alpha-1 in immature teratomas. Am J Clin Pathol (2008) 0.75
Localized candidiasis in kidney presented as a mass mimicking renal cell carcinoma. Case Rep Infect Dis (2012) 0.75
T cell receptor gamma-chain gene polymerase chain reaction to diagnose central nervous system involvement by cutaneous T cell lymphoma. J Mol Diagn (2002) 0.75
Atherosclerotic 18F-FDG and MDP uptake in femoral arteries, changes with age. Nucl Med Commun (2016) 0.75
The use of immunohistochemical expression of SF-1 and EMA in distinguishing adrenocortical tumors from renal neoplasms. Appl Immunohistochem Mol Morphol (2012) 0.75
Metabolic effects of pulmonary obstruction on myocardial functioning: a pilot study using multiple time-point 18F-FDG-PET imaging. Nucl Med Commun (2015) 0.75
ACR appropriateness criteria on obstructive voiding symptoms secondary to prostate disease. J Am Coll Radiol (2010) 0.75
Molecular analysis of gastric washings in the diagnosis and monitoring of gastric lymphomas. Hum Pathol (2004) 0.75
Partial volume correction and image segmentation for accurate measurement of standardized uptake value of grey matter in the brain. Nucl Med Commun (2015) 0.75
Hearing status in children with frequently relapsing and steroid resistant nephrotic syndrome. Pediatr Nephrol (2012) 0.75